Skip to main content

Calithera Biosciences, Inc.

CALADelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001496671

Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.

Holders of 5% or more of CALA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Calithera Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Calithera Biosciences, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Calithera Biosciences, Inc., newest first.

No Schedule 13D or 13G filings on Calithera Biosciences, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Calithera Biosciences, Inc. shares.

No Form 144 notices for Calithera Biosciences, Inc. are on file.